AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
FDA Roundup Shows Medtech Regulation Is Entering a More AI-Native Phase
May’s FDA roundup captures a regulatory environment that is increasingly shaped by AI, device lifecycle management, and the growing complexity of digital health products. The roundup’s significance lies in how it frames medtech regulation not as a static gatekeeping function, but as a moving target adapting to faster-moving technology.
FDA Roundup Signals a Busy Month for Medtech as CDRH Marks 50 Years
A May regulatory roundup highlights that Makary’s initiatives remain in place at FDA while the CDRH marks 50 years of medtech regulation. The update matters because it frames how device makers should read the current policy environment: stable on some fronts, still evolving on others.
FDA Review Leader Pushes New Frameworks as CDRH Modernizes Its Approach to Innovation
At MedCon, the CDRH director outlined innovation, modernization, and new regulatory frameworks as priorities for the device center. The comments suggest the FDA is trying to keep pace with faster-moving technologies by rethinking how it evaluates products and evidence.
CDRH Director Tarver Signals More AI Guidance Is Coming
At an AAMI event, FDA device chief CDRH Director Tarver previewed more AI guidance, suggesting regulators are preparing additional rules for how AI-enabled medical devices should be assessed. The signal matters because the sector is moving from experimental enthusiasm into a phase where clearer expectations will shape product design and submission strategy.
FDA’s AI Guidance Preview Signals a More Structured Era for Medical Device Review
CDRH Director Tarver previewed upcoming AI guidance at an industry event, hinting at a more explicit regulatory framework for AI-enabled devices. The move suggests the FDA wants to give industry clearer expectations without slowing innovation to a crawl.
FDA patient preference guidance signals a broader evidence model for medical devices
New CDRH guidance on patient preference information highlights the FDA’s continued push to incorporate patient values into device decision-making. The policy is notable because it widens the definition of meaningful evidence beyond technical performance and traditional clinical endpoints.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.